Investing Ideas
/
U.K. Pharmaceuticals & Biotech Financially Fit Penny Stocks

U.K. Pharmaceuticals & Biotech Financially Fit Penny Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

1 new

A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses

26 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
LLAI LungLife AI	UK£0.09	-5.3%	-80.6%	UK£2.8m	UK£1.71	PS119.6x	E101.0%	n/a
EAH ECO Animal Health Group	UK£0.71	2.9%	-35.7%	UK£48.1m	UK£1.60	PE73.1x	E39.2%	0%
AREC Arecor Therapeutics	UK£0.69	1.5%	-61.9%	UK£26.2m	UK£3.64	PS5.4x	E-1.8%	n/a
C4XD C4X Discovery Holdings	UK£0.12	45.9%	-16.4%	UK£30.3m	UK£0.48	PE2.9x	E-88.3%	n/a
N4P N4 Pharma	UK£0.0053	-12.5%	-41.7%	UK£2.1m	n/a	PS353.7x	n/a	n/a
FUM Futura Medical	UK£0.32	-3.7%	24.1%	UK£97.0m	UK£1.34	PS11.6x	E188.3%	n/a
PBX ProBiotix Health	UK£0.058	-11.5%	-17.9%	UK£9.1m	n/a	PS4.3x	n/a	n/a
FAB Fusion Antibodies	UK£0.067	3.9%	57.6%	UK£6.4m	n/a	PS3.6x	n/a	n/a
FARN Faron Pharmaceuticals Oy	UK£1.65	-2.9%	-45.0%	UK£172.6m	UK£10.00	PB150.9x	E11.7%	n/a
SNG Synairgen	UK£0.02	-54.4%	-69.7%	UK£4.1m	UK£0.08	PB0.4x	E50.2%	n/a
STX Shield Therapeutics	UK£0.027	-0.9%	-57.8%	UK£21.3m	UK£0.17	PS1.2x	E84.4%	n/a
TRX Tissue Regenix Group	UK£0.59	2.6%	13.3%	UK£42.4m	UK£1.20	PS1.7x	E170.8%	n/a
DXRX Diaceutics	UK£1.26	5.0%	39.4%	UK£106.0m	UK£1.75	PS4.1x	E83.5%	n/a
NFX Nuformix	UK£0.0005	-4.8%	-82.1%	UK£409.7k	n/a	PB0.1x	n/a	n/a
VAL ValiRx	UK£0.0073	-6.5%	-88.2%	UK£959.5k	n/a	PS100x	n/a	n/a
POLB Poolbeg Pharma	UK£0.071	-0.7%	-22.7%	UK£35.8m	UK£0.19	PB2.9x	E-13.1%	n/a
APTA Aptamer Group	UK£0.0035	-9.1%	-70.2%	UK£6.7m	n/a	PS7.8x	n/a	n/a
TCF Theracryf	UK£0.0053	0%	-67.2%	UK£2.3m	UK£0.11	PB0.8x	E37.3%	n/a
OPTI OptiBiotix Health	UK£0.18	-16.3%	-29.0%	UK£17.4m	n/a	PS30.6x	n/a	n/a
0HMP New Bellerophon Therapeutics	US$0.04	0%	23.8%	US$489.3k	n/a	PS0.09x	n/a	47.4%
SAR Sareum Holdings	UK£0.27	1.9%	-50.9%	UK£33.7m	n/a	PB15.9x	n/a	n/a
HEMO Hemogenyx Pharmaceuticals	UK£3.43	-18.2%	-59.1%	UK£12.0m	n/a	PB3.9x	n/a	n/a
SBTX SkinBioTherapeutics	UK£0.17	-10.7%	9.8%	UK£38.3m	UK£0.56	PS31.7x	n/a	n/a
CIZ Cizzle Biotechnology Holdings	UK£0.018	-2.8%	-14.6%	UK£6.9m	n/a	PB8.7x	n/a	n/a

Page 1 of 2